Oncology patients will be included. No exclusion of specific entities or stages.
Conditions
Interventions
Group 1: Observational study:
Oncology patients will complete the following questionnaires once:
DS-II, LAP-R Choice Responsibility, FBK-R23, FACT-G, PHQ-9, GAD-7, SAHD-D, OPD-SFK.
In addition, the
Sponsors
H.W. & J. HECTOR STIFTUNG
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Oncological diagnosis German as native language or very good knowledge of German Written consent to participate
Exclusion criteria
Exclusion criteria: Psychiatric disorders: Psychotic disorder ICD-11: F2 diagnosis; Substance dependence or abuse ICD-11: F1 diagnosis) Insufficient knowledge of German Severe psychiatric comorbidity Lack of written informed consent for Participation in the study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The planned study will examine the need for cancer-specific suicidality screening by describing the causes, function and meaning of suicidal ideation and death wishes in cancer patients. It will also explore and describe the role of feelings of demoralisation, loss of control and distress in the development of suicidal ideation and death wishes. It will also explore how patients would like to deal with suicidality and how they would like to discuss it. The pilot study will provide initial data that will be used to adapt the study procedure and survey instruments for the main study, if necessary. | — |
Countries
Germany
Contacts
Public ContactLaura Pfannstiel
Universitätsklinik Würzburg
Outcome results
None listed